|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 31/436 | (2013.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 9/12 | (2018.01) |
| (11) | Patento numeris | 3821891 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20211109.2 |
| Europos patento paraiškos padavimo data | 2012-04-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-05-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161481317 P | 2011-05-02 | US |
| (72) |
SPIEKERKOETTER, Edda , US
RABINOVITCH, Marlene , US
BEACHY, Philip, A. , US
SOLOW-CORDERO, David , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
| USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |